Hematologic Malignancies Flashcards

1
Q

5 types of leukemia

A
  1. chronic lymphocytic leukemia
  2. chronic myelogenous leukemia
  3. acute myelogenous leukemia
  4. actue lymphoblastic leukemia
  5. acute promyelocytic leukemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

4 types of lymphoma

A
  1. Hodgkin’s Lymphoma
  2. Non-Hodgkin’s lymphoma
  3. Follicular lymphoma
  4. Diffuse large B-cell lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hem. malignancy not leukemia or lymphoma

A

multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How common are hematologic malignancies

A

not very

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what cell type are most hem. malignancies in?

A

B cells, not T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chronic lymphocytic leukemia (CLL)

- risk factors

A
  • runs in families
  • herbicides
  • viruses (HTLV I & II and Epstein- Barr)
  • Not radiation or alkylating agents

**not really sure what the exact cause is still…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chronic lymphocytic leukemia (CLL)

Clinical presentation

A
  • 25% asymptomatic, often high WBC found on CBC run for something else

If symptomatic

  • lymphadenopathy
  • splenomegaly
  • hepatomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chronic lymphocytic leukemia (CLL)

in general, what is happening

A

So many lymphocytes in marrow compromises the ability to make other cells (anemic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chronic lymphocytic leukemia (CLL)

- lab presentation

A
  • WBC > 100,000
  • Hgb < 11
  • Platelets <100,000
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic lymphocytic leukemia (CLL)

- Dx criteria

A
  1. Absolute lymphocyte count of => 5,000/mm3
  2. Lymphocytes are monoclonal (all come from the same malignant stem cell)
  3. Low levels of surface immunoglobulins
  4. Bone marrow is min 30% lymphocytes
  5. Rule out other causes of lymphocytosis (mono, pertussis, toxo)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the purpose of staging in hematology and oncology

A
  • standardize descriptions of disease state

- provides prognostic info to help discussions with pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chronic lymphocytic leukemia (CLL)

Staging - list two kinds, what are they based on

A
  1. Rai classification
  2. Binet classification
    - both reflect tumor burden
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic lymphocytic leukemia (CLL)

Rai classification: what happens as go from stage 1 to 5

A
  • months of survival decrease if untreated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic lymphocytic leukemia (CLL)

- Rai 5 stages

A
0 lymphocytosis
I lymphocytosis adenopathy
II Lymphocytosis, hepatomegaly or splenomegaly
III Lymphocytosis, anemia
IV thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chronic lymphocytic leukemia (CLL)

Binet staging

A

A - lymphocytosis and =< 3 enlarged nodal groups
B - lymphocytosis and >3 enlarged nodal groups
C - lymphocytosis, anemia, or thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are common maladies associated with Chronic lymphocytic leukemia (CLL) (3)

A
  1. autoimmune hemolytic anemia (most common)
  2. immune thrombocytopenia
  3. infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anemia in CLL and AHA

A

Anemia will show up in AHA but isn’t considered when staging CLL because it is not due to the CLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why is CLL at greater risk for infection?

A

Lack of surface immunoglobulins

most common cause of death in people with CLL is infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How true is the statement “CLL is an indolent disease associated with a 10 to 20 year clinical course with death unrelated to CLL”

A

< 30% of the time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are good prognostic sx in CLL

A
  1. Low Rai or Binet clinical stage
  2. Nodular findings on bone marrow study (vs. interstitial which is worse)
  3. Lymphocyte doubling >12 months
  4. Mutated Vh genes
  5. ZAP-70 negativity
  6. Chromosome 13q14
  7. CD38 negativity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic lymphocytic leukemia (CLL)

Treatment indications

A
  1. fever, night sweats
  2. weight loss
  3. progressive anemia
  4. thrombocytopenia
  5. progressive/painful splenomegaly
  6. progressive/bulky lymphadenopathy
  7. rapidly increasing lymphocytosis
  8. autoimmune cytopenias (low platelets or anemia)

**might not treat right away if pt is asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Chronic lymphocytic leukemia (CLL)

  • evidence for early treatment
  • curable?
  • what drives treatment?
A
  • no evidence for early therapy
  • not curable (except with stem cell transplant that can be used on people who have tried and failed treatment and dx is still progressing)
  • tx is sx driven
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Chronic lymphocytic leukemia (CLL)

- Treatment

A
  • Alkylators
  • Prednisone
  • Imbruvica
  • monoclonal antibodies
  • lots of others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Chronic Myelogenous Leukemia (CML)

- blood smear

A
  • Lots of immature cells in peripheral smear
  • These cells should be in blood marrow
  • won’t see a lot of blasts unlike leukemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Chronic Myelogenous Leukemia (CML)

  • median age range at presentation
  • what increases incidence
  • male vs. female
  • how most often found?
A
  • 45 to 55, middle age disease
  • incidence increases with age (12-30% >60 yo)
  • M>F
  • 50% dx by routine lab test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Chronic Myelogenous Leukemia (CML)

- clinical presentation

A
  • 50% asymptomatic!
  • fatigue, weight loss, abdominal fullness
  • palpable splenomegaly common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Chronic Myelogenous Leukemia (CML)

- lab findings

A
  • abnormal differential
  • leukocytosis
  • thrombocytosis
  • anemia
  • basophilia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Chronic Myelogenous Leukemia (CML)

- three phases

A
  1. chronic phase
  2. accelerated (advanced phase)
  3. blast crisis (advanced phase)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Chronic Myelogenous Leukemia (CML)

- chronic phase: duration, lab findings, associated issue

A

median 5-6 years stabilization

  • elevated WBC
  • elevated platelets
  • anemic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Chronic Myelogenous Leukemia (CML)

- Accelerated phase: duration, lab finding

A
  • 6-9 months

- lots of basophils on peripheral smear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Chronic Myelogenous Leukemia (CML)

- blast crisis: duration, lab finding

A
  • 3-6 months survival

- surplus of myeloblasts in peripheral smear (>30%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Chronic Myelogenous Leukemia (CML)

- caused by what

A
  • philadelphia chromosome (9 & 22) also known as Bcr-Abl
  • activates tyrosine kinase which makes cell immortal.
  • causes transformation of hematopoietic progenitor into malignant clone
  • first malignancy where specific abnormality was found that causes the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What disease(s) is Philadelphia chromosome found in?

A
  • CML: almost 100%
  • ALL adult and pediatric
  • AML
    • found less often in ALL and AML
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Chronic Myelogenous Leukemia (CML)

- new treatment type

A

Tyrosine kinase inhibitors - if can inhibit tyrosine kinase, will shut down cell and it will die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the two acute leukemias

A
  • AML (acute myelogenous leukemia)

- ALL (acute lymphoblastic leukemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What lab finding is only found in AML?

A

Auer Rods (little sticks coming off the granule into the cytoplasm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

AML vs. ALL

- which one common in childhood, which in adults

A
  • 90% adult leukemia is AML

- 80% childhood leukemia is ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

When does incidence of ALL decrease?

A

after age 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

when does incidence of AML increase?

A
  • with age

- 30% after age 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Male or female more likely to get AML

A

males - as infant and elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What causes AML/ALL

A
  • Radiation,
  • viruses?
  • benzene, toluene, other chemicals
  • drugs: alkylators, arsenicals, etc
  • Hereditary: Bloom’s syndrome (AML)
  • Fanconi’s anemia (AML)
  • Trisomy 21: AML and ALL
  • Siblings - 5X risk among siblings, 25% risk with monozygotic twins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

AML and ALL

- sx

A
  • fatigue, fever, weight loss
  • HA
  • Cranial nerve palsies (chin and facial numbness), obstipation
  • bone pain and abdominal fullness from splenomegaly more common in ALL
  • bone pain common in kids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

AML & ALL

- PE findings

A
  • pallor, petechia, purpura (from thrombocytopenia)
  • sternal pain, lymphadenopathy, hepatosplenomegaly (ALL > AML)
  • meningismus (stiff neck) (ALL>AML)
  • flame hemorrhage in fundus exam
  • gingival enlargement
  • bleeding/DIC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Initial work up for leukemia

A
  1. H&P
  2. CBC, PT/PTT, Fibrinogen
  3. Bone marrow aspiration/biopsy
  4. morphology: determine what cell line dealing with
  5. cytochemistry
  6. immunophenotyping
  7. FISH (older cytogenetics) to look at DNA
  8. HLA-typing: Human lymphocyte antigen typing to find stem cell donors.
  9. Cardiac scan to help with medication selection
  10. FLT-4. a molecular mutation. If have, bad news
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

When is a bone marrow exam appropriate for leukemia?

A

> 20% blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Three cytogenetic findings in leukemia

A
  1. Auer rods = AML
  2. Terminal transferase (TdT) = ALL
  3. Peroxidase = AML
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

what anemia is most commonly found in leukemia?

A

hypoproliferative
normochromic
normocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

WBC findings in leukemia

A

leukocytosis 60%
leukopenia 25%
normal 15%
thrombocytopenia 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what happens when treat a malignant tumor (findings in blood)

A

the tumor cells lyse and dump:

  • k+ (cardiac arrhythmia)
  • uric acid (kidney failure)
  • creatine
  • PO4 up and mg down which causes musculoskeletal problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

When check CSF?

A
  • Always with ALL (might wait until “count” goes down)

- AML if signs or symptoms present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

AML

- what used to stage?

A

“FAB”
french-american-british
M0-M7

52
Q

What is a good prognosis for AML

A
  • WBC < 39,000
  • LDH - normal (reflection of cell turnover)
  • translocations 8;21
  • M4 with eosinophils
  • Inv 16
  • (15;17)
53
Q

AML bad prognosis

A
  • secondary leukemia (ex. breast cancer)
  • Myelodysplastic syndrome
  • CD34 + blasts
  • p-glycoprotein positive
  • MDR gene (multidrug resistent gene)
54
Q

Myelodysplastic syndrome

A
  • usually in older its who show up with abnormal CBC, pancytopenia, possibly thrombocytopenia
  • some will evolve into acute leukemia which is worse than de novo
55
Q

Three stages of leukemia treatment

A
  1. induction
  2. consolidation
  3. maintenance
  4. post-remission therapy
56
Q

Induction - leukemia treatment

A

induce a remission via chemotherapy

57
Q

Consolidation - leukemia treatment

A

Once in remission, keep getting chemotherapy. May be same drug used in induction at same level of intensity or less intense level

58
Q

Maintenance - leukemia treatment

A

After induction and consolidation, want to maintain that remission. Mandatory in treatment of ALL (3-5 years)

59
Q

Post remission therapy - leukemia treatment

A

can be maintenance, can be something like a stem cell transplant (depending on how favorable or unfavorable the cancer is at that point)

60
Q

5 Meds used to for AML induction and consolidation

A
  1. Daunomycin + cytarabine (Ara-C)
  2. Idarubicin + Cytarabine (Ara-C)
  3. High dose Ara-C
  4. Gemtuzumab ozogamicin (monoclonal antibody)
  5. Vyxeos
61
Q

SWOG 9034

A

Not sure exactly but I think some sort of study that links mortality of leukemia to whether they are considered favorable, intermediate, or unfavorable.

  • favorable 60% are expected to live 5 years
  • unfavorable 20% are expected to live 5 years
62
Q

Acute promyelocytic leukemia (APL)

- treatment

A
  • completely different from other myeloproliferative diseases.
  • don’t miss: the treatment is very effective!
  • transretinoic acid and arsenic (the chinese reported these work and western world keeps thinking they are crazy)
63
Q

what is a common problem associated with Acute promyelocytic leukemia (APL)

64
Q

Who first described lymphoma? when?

A

Thomas Hodgkin in 1832

65
Q

Who made first definitive and thorough microscopic description of lymphoma?

A

Sternberg and Reed

66
Q

Hodgkin’s vs. non-Hodgkin’s lymphoma - which is more common

A

NHL by a lot

67
Q

What origin are most lymphomas?

A

B-cell origin

68
Q

Three types of NHL

A
  1. diffuse large B - cell
  2. Follicular
  3. Other NHL
69
Q

Hodgkin’s Lymphoma

  • how common
  • men vs. women
  • less common in what race
  • does it run in families?
A
  • uncommon
  • M > F
  • less common in african americans
  • does run in families
70
Q

Hodgkin’s Lymphoma

  • Age of incidence
  • likely cause?
A
  • bimodal: young and old people
  • childhood happens in underdeveloped countries
  • likely related to virus, maybe Epstein barr?
71
Q

Hodgkin’s Lymphoma

- what cells are found in peripheral smear?

A
  • Reed-sternberg cells aka Owl Eyes
  • arise in lymph nodes
  • germinal centre b-cells
72
Q

what is the cellular composition of enlarged lymph nodes in Hodgkin’s lymphoma?

A
  • most are recruited lymphocytes (polyclonal reactive lymphoid cells)
  • only a minority of cells are malignant (unlike other cancer tumors when most of the cells are malignant)
73
Q

What are the 5 types of Hodgkin’s lymphoma

A
  1. Nodular sclerosis
  2. Mixed cellularity
  3. Lymphocyte-rich
  4. Lymphocyte depleted or not depleted
  5. Nodular lymphocyte-predominant (controversy if Hodgkin or NHL)

** all treated essentially the same way except #5, all have slightly different prognoses

74
Q

What are the three main components of the lymphatic system

A
  1. lymphocytes
  2. lymphoid organs
  3. lymphocyte circulation
75
Q

What are the 6 lymphoid organs?

A
  1. bone marrow
  2. thymus
  3. lymph nodes
  4. spleen
  5. tonsils, adenoids
  6. digestive and respiratory tract
76
Q

What system is used to stage Hodgkin’s Lymphoma

A

Ann-Arbor staging

stages 1-4

77
Q

Stage 1 Hodgkin’s Lymphoma

A
  • localized disease
  • single lymph node region
  • single organ outside the lymph nodes
78
Q

Stage 2 Hodgkin’s Lymphoma

A

Two or more lymph node regions near each other (on the same side of the diaphragm)

79
Q

Stage 3 Hodgkin’s Lymphoma

A

Two or more lymph node regions above and below the diaphragm

80
Q

Stage 4 Hodgkin’s Lymphoma

A
  • widespread disease
  • multiple organs (liver and bone marrow most common)
  • with or without lymph node involvement
81
Q

What determines how treat Hodgkin’s lymphoma

A

staging of the disease

82
Q

How treat Hodgkin’s lymphoma in stages 1 and 2

A
  • Radiation

- Unless have B symptoms, then might get radiation and chemo

83
Q

Hodgkin’s lymphoma B symptoms

A

feel ill
night sweats
weight loss

84
Q

How treat Hodgkin’s lymphoma in stages 3 and 4

A
  • chemotherapy
85
Q

what is moving into front line therapy for How treat Hodgkin’s lymphoma

A

monoclonal antibodies

86
Q

Non-Hodgkin’s lymphoma (NHL)

- S&S

A
  • enlarged lymph nodes
  • general symptoms (weight loss, fatigue, night sweats, fever, severe itching)
  • less than 20% of pts have general sx at onset
87
Q

Non-Hodgkin’s lymphoma (NHL)

- risk factors

A
  • environmental - chemicals and high-dose radiation
  • immunosuppression (biologics, AIDS, post-organ transplant)
  • viral and bacterial infections (HTLV-1, EBV, H pylori)
  • inherited - small %

**cause is unknown

88
Q

Non-Hodgkin’s lymphoma (NHL)

- how is it related to age

A

incidence increases with age

89
Q

Non-Hodgkin’s lymphoma (NHL)

- dx

A
  • Biopsy (FNA, excisional/incisional, bone marrow, LP)
  • Laboratory testing
  • Imaging (chest x-ray, CT, MRI, PET)
90
Q

why is FNA not a great way to dx NHL

A

only know it is lymphoma, not whether HL or NHL…

91
Q

What labs would run to dx NHL

A
  • CBC
  • Chem panel
  • Liver panel
  • LDH (would be elevated in rapidly dividing tumor)
92
Q

Three types of NHL B-cell neoplasms

A
  1. Indolent - slow growing, CLL + small lymphocytic leukemia
  2. Aggressive - diffuse large b-cell most common
  3. Very aggressive - precursor B cell and Burkitt
93
Q

3 factors that influence treatment of Lymphoma

A
  1. Grade (growth rate and aggressiveness)
  2. Cell type
  3. Stage (extent of spread)
94
Q

What system used to grade NHL?

A

Ann Arbor, same as HL

95
Q

What is difference between staging of HL and NHL?

A

HL: stage determines prognosis, stepwise progression through each stage
NHL: prognosis determined by cell type, diff biological behavior of diff cells, no stepwise progression like HL

96
Q

Indolent lymphoma - treatment and reaction

A
  • slow progression
  • responds well to initial treatment,
  • chronic disease with periods of relapse
97
Q

Aggressive lymphoma - progression, how easy to treat

A
  • rapid progression

- easier to cure

98
Q

Types of lymphoma treatment

A
  1. radiation (early stage indolent)
  2. Chemo (advanced stage)
  3. Chemoradiation (early stages)
99
Q

Three common lymphomas1

A
  1. follicular
  2. diffuse large b-cell
  3. Hodgkin’s
100
Q

Follicular lymphoma

  • which type
  • response to treatment
  • cell or origin
A
  • most common type of indolent
  • frequency stage 4 when dx (already spread to lymph node)
  • often asymptomatic
  • not curable but treatable for a long time
  • cell of origin is germinal center B cell
101
Q

How treat follicular lymphoma

A
  • defer tx if asymptomatic
  • chemo if symptomatic
  • over time can become more aggressive and turn into diffuse large b-cell lymphoma…
102
Q

Diffuse large B-cell lymphoma

  • which type
  • cell of origin
  • sx?
  • treatment
  • treatment success
A
  • most common type of “aggressive” lymphoma
  • cell or origin: germinal center B-cell
  • usually symptomatic
  • should offer treatment
  • 60-70% cured after monoclonal antibody drug therapy
103
Q
Multiple Myeloma (MM)
- peripheral smear
A
  • perinuclear pallor
  • multiple nuclei in single cell
  • way too many plasma cells
104
Q
Multiple Myeloma (MM)
- x-ray findings
A
  • fractures (duh)
  • dark areas/mottling of bone
  • changes from plasma cells which dissolve the bone
  • lytic lesions
105
Q

Plasma cell dyscrasias 6 types

A
  1. multiple myeloma
  2. smoldering myeloma
  3. solitary plasmacytoma of bone
  4. monoclonal gammopathy of unknown significance (MGUS)
  5. amyloid
  6. Waldenstrom’s macroglobulinemia
106
Q

Smoldering myeloma

A

too many plasma cells but no end organ damage yet

107
Q

Solitary plasmacytoma of bone

A
  • one area of plasma cells forms a tumor “plasmacytoma”

- can treat with radiation

108
Q

Monoclonal gammopathy of unknown significance (MGUS)

A
  • prob all myelomas arise from MGUS but not all MGUS become MM
  • as age, get monoclonal changes,
109
Q

Amyloid plasma cell dyscrasias

A

plasma cells make abnormal immunoglobulins and light chains (deposited in tissues, kidneys, heart, liver)

110
Q

Waldentstrom’s Macroglobulinemia

A

IgM: huge molecule that causes hyper viscosity of blood.

111
Q

Multiple Myeloma (MM)

  • what does NOT cause
  • what might cause
  • what race most common in
  • m vs. f
  • appears to develop from what
A
  • NOT radiation, solvents, paints, pesticides
  • NO epidemiological clusters
  • maybe human herpes virus
  • 2X incidence in AA
  • M > F
  • appears to develop from MGUS
112
Q

End organ damage critera

A

CRAB

  • Calcium (high)
  • Renal (Failure)
  • Anemia
  • Bone (disease)
113
Q

How test for CRAB

A
  • chem panel for calcium, kidney fn, anemia

- metastatic skeletal survey for bones (series of x-rays to look at every bone in the body OR PET scan but more $$)

114
Q
Multiple Myeloma (MM)
- two staging systems
A
  1. Durie-Salmon staging system

2. International Staging System (ISS)

115
Q
Multiple Myeloma (MM)
- Durie-Salmon staging system stage I
A

All of the following:

  • Hgb > 10 g/dL
  • normal serum calcium
  • bone x-ray normal/solitary bone plasmacytoma
  • low M protein production
  • urine light chain M-component on electrophoresis
116
Q
Multiple Myeloma (MM)
- Durie-Salmon staging system stage II
A

Not stage I or III

117
Q
Multiple Myeloma (MM)
- Durie-Salmon staging system stage III
A

One or more of the following:

  • Hgb <8.5 g/dL
  • serum ca >12 mg/dL
  • advanced lytic bone lesions
  • high M protein production rates
  • Bence Jones protein >12 g/24 hours
118
Q

Multiple Myeloma (MM)
ISS
- how common
- response to therapy and prognosis stage 1-3

A
  • less common than Durie-Salmon

- stage 1 has better response to therapy and more fav prognosis than Stage II and III

119
Q

Treatment of Multiple Myeloma (MM)

A
  • Alkalators
  • steroids
  • immunomodulating agents (Thalamide was first)
  • proteosome inhibitors
  • monoclonal antibodies
  • autologous stem cell transplantation
120
Q

KAR-T Cells

A
  • Pre-B cell ALL and <25 yo
  • diffuse large b-cell lymphoma
  • maybe MM and solid tumors in future
121
Q

Kar-T cell tx

A
  • separate T cells from blood
  • send to NJ where mix T cells with virus which sticks in receptor that looks at part of the B cell malignancy
  • cells back to pt
  • new T cells recognize B cell and kills it, T cells live for years and will kill new emergences of disease in future
  • will be IgG dependent for life bc all B cells are dead (downside)
122
Q

In summary…

- what is common about all hematologic disorders

A
  • non specific sx of fatigue, weight loss, fever
123
Q

In summary…

- what should do with even mild CBC abnormalities

A

pay attention! Evaluate

124
Q

In summary…

- what type of lymph node needs attn

A

persistent >1 cm

125
Q

In summary…

- how treatable are hematologic disorders

A

usually highly treatable which means missing one is really bad…